Improved long-term survival in multiple myeloma up to the age of 80 years (Q87087951)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 14 January 2014

Language	Label	Description	Also known as
English	Improved long-term survival in multiple myeloma up to the age of 80 years	scientific article published on 14 January 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24418994%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Improved long-term survival in multiple myeloma up to the age of 80 years (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24418994%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

multiple myeloma

1 reference

based on heuristic

inferred from title

author name string

S Y Kristinsson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24418994%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

W F Anderson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24418994%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

O Landgren

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24418994%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

14 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24418994%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24418994%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24418994%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24418994%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1346-1348

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24418994%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Multiple Myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24418994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Racial disparities in incidence and outcome in multiple myeloma: a population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24418994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24418994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The molecular classification of multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24418994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24418994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent major improvement in long-term survival of younger patients with multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24418994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treating myeloma: the future is already here!

1 reference

https://pubmed.ncbi.nlm.nih.gov/24418994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24418994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24418994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24418994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24418994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved survival in multiple myeloma and the impact of novel therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/24418994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24418994

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q87087951&oldid=2221923962"